Literature DB >> 16861609

Early decreases in plasma lipid transfer proteins during weight reduction.

Themistoklis Tzotzas1, Laure Dumont, Athanasios Triantos, Michael Karamouzis, Theodoros Constantinidis, Laurent Lagrost.   

Abstract

OBJECTIVE: To determine the effect of short-term weight loss in obese women on concentrations of plasma cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP), two new risk factors for cardiovascular disease. RESEARCH METHODS AND PROCEDURES: Plasma CETP and PLTP mass concentrations were measured in 38 obese, non-diabetic women before and after a moderate, 4% weight loss that was obtained by a 1250 kcal/d diet for 4 weeks. Anthropometric and biological parameters were measured before and after weight loss.
RESULTS: Plasma CETP concentration decreased substantially after weight loss (2.76 +/- 0.79 before and 2.31 +/- 0.69 mg/L after; p = 0.000), and the same was true for plasma PLTP concentration (9.01 +/- 2.44 mg/L before vs. 8.34 +/- 2.57 after; p = 0.043). The HDL profile shifted toward the small-sized range, with significant decreases in the relative abundance of HDL(2b) and HDL(2a) at the expense of HDL(3b) after weight loss. A significant, positive correlation between CETP and PLTP mass concentrations is reported for the first time in obese patients (r = 0.43, p = 0.004), and weight reduction was accompanied by early, concomitant, and parallel decreases in plasma CETP and PLTP levels (r = 0.47, p = 0.003). The significant relationship between CETP and PLTP levels was lost after the dietary intervention (r = 0.27; p = 0.11). DISCUSSION: CETP and PLTP correlate positively and significantly in obese patients. The hypocaloric dietary manipulation constitutes a relevant intervention to reduce rapidly and simultaneously plasma levels of CETP and PLTP. The impact of reduced PLTP activity on HDL size appeared to be more prominent than the impact of concomitant reduction in CETP activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861609     DOI: 10.1038/oby.2006.119

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

Review 1.  Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Authors:  Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation.

Authors:  Xiao-Min Zhao; Yun Wang; Yang Yu; Hui Jiang; Anna Babinska; Xiu-Yu Chen; Ke-Gui He; Xiang-Dong Min; Ji-Ju Han; Chen-Xi Yang; Kevin Deng; Jing Xue; Xiangjian Zhang; Guo-Hua Song; Shu-Cun Qin; Xian-Cheng Jiang
Journal:  Thromb Haemost       Date:  2018-11-12       Impact factor: 5.249

Review 3.  Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis.

Authors:  Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

4.  Exchanging carbohydrate or protein for fat improves lipid-related cardiovascular risk profile in overweight men and women when consumed ad libitum.

Authors:  Mario Kratz; David S Weigle; Patricia A Breen; Kaatje E Meeuws; Verna R Burden; Holly S Callahan; Colleen C Matthys; Jonathan Q Purnell
Journal:  J Investig Med       Date:  2010-06       Impact factor: 2.895

5.  Effects of weight loss on lipid transfer proteins in morbidly obese women.

Authors:  Markus W Laimer; Julia Engl; Alexander Tschoner; Susanne Kaser; Andreas Ritsch; Tobias Tatarczyk; Markus Rauchenzauner; Helmut Weiss; Franz Aigner; Josef R Patsch; Christoph F Ebenbichler
Journal:  Lipids       Date:  2009-09-30       Impact factor: 1.880

6.  Serum CETP and PLTP activity in middle-aged men living in urban or rural area of the Lower Silesia region. PURE Poland sub-study.

Authors:  Anna Skoczyńska; Anna Wojakowska; Barbara Turczyn; Katarzyna Zatońska; Maria Wołyniec; Andrzej Szuba
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

7.  Prodomain of Furin Promotes Phospholipid Transfer Protein Proteasomal Degradation in Hepatocytes.

Authors:  Yang Yu; Xia Lei; Hui Jiang; Zhiqiang Li; John W M Creemers; Ming Zhang; Shucun Qin; Weijun Jin; Xian-Cheng Jiang
Journal:  J Am Heart Assoc       Date:  2018-04-21       Impact factor: 5.501

8.  Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.

Authors:  Marjorie Boyer; Valérie Lévesque; Paul Poirier; André Marette; Patricia L Mitchell; Samia Mora; Patrick Mathieu; Jean-Pierre Després; Éric Larose; Benoit J Arsenault
Journal:  J Am Heart Assoc       Date:  2018-06-01       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.